Paysign Inc reports results for the quarter ended June 30 - Earnings Summary
Paysign Inc reports results for the quarter ended June 30 - Earnings Summary
Paysign Inc PAYS.OQ reported quarterly adjusted earnings of 11 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 2 cents. The mean expectation of four analysts for the quarter was for earnings of 6 cents per share.
Revenue rose 48.1% to $28.25 million from a year ago; analysts expected $26.35 million.
Paysign Inc's reported EPS for the quarter was 11 cents.
The company reported quarterly net income of $6.76 million.
Paysign Inc shares had risen by 13.3% this quarter and gained 80.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 4.3% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the business support services peer group is also "buy"
Wall Street's median 12-month price target for Paysign Inc is $11.00, about 12.8% above its last closing price of $9.59
This summary was machine generated from LSEG data August 5 at 10:40 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.06 | 0.11 | Beat |
Mar. 31 2026 | 0.07 | 0.09 | Beat |
Dec. 31 2025 | 0.02 | 0.02 | Met |
Sep. 30 2025 | 0.02 | 0.04 | Beat |
Recent news on Paysign
See all newsU.S. STOCKS ON THE MOVE-Braveheart Bio, Paysign, Hertz Global
Paysign surges to near 7-yr high after results, outlook
Paysign Inc reports results for the quarter ended June 30 - Earnings Summary
Paysign Q2 revenue beats estimates; outlook raised amid pharma program expansion
Brief: Paysign Q2 Revenue USD 28.3 Million Vs. IBES Estimate USD 26.3 Million